Zalicus Pharmaceuticals, Ltd.
8Patents
8Active
8Granted
44Portfolio score
Filing activity: May 4, 2007 → Aug 29, 2013 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8133998B2 | Bicyclic pyrimidine derivatives as calcium channel blockers | Human Necessities | 48 | Active |
| US8377968B2 | N-piperidinyl acetamide derivatives as calcium channel blockers | Chemistry; Metallurgy | 5 | Active |
| US8569344B2 | N-piperidinyl acetamide derivatives as calcium channel blockers | Chemistry; Metallurgy | 4 | Active |
| US9096522B2 | N-piperidinyl acetamide derivatives as calcium channel blockers | Chemistry; Metallurgy | 4 | Active |
| US8409560B2 | Solid dispersion formulations and methods of use thereof | Human Necessities | 2 | Active |
| US8591944B2 | Solid dispersion formulations and methods of use thereof | Performing Operations; Transporting | 1 | Active |
| US8629149B2 | Oxopiperazine derivatives for the treatment of pain and epilepsy | Human Necessities | 1 | Active |
| US8362021B2 | Method for increasing the bioavailability of benzhydryl piperazine containing compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.